0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Generic Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-37X5172
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Generic Injection Market Insights Forecast to 2028
BUY CHAPTERS

Generic Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37X5172
Report
November 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Generic Injection - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Generic Injection - Market

Generic Injection - Market

Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global market for Generic Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Generic Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Generic Injection by region & country, by Type, and by Application.
The Generic Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.
Market Segmentation

Scope of Generic Injection - Market Report

Report Metric Details
Report Name Generic Injection - Market
CAGR 5%
Segment by Type:
  • Liquid Injection
  • Powder for Injection
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals, Gland Pharma, Allergan, Kelun Pharmaceutical, Jiangsu HRS, Qilu Pharmaceutical, Chiatai Tianqing, Hainan Poly Pharm, Yangzijiang Pharmaceutical Industry, Shijiazhuang Pharma Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Generic Injection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Generic Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Generic Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Generic Injection - Market report?

Ans: The main players in the Generic Injection - Market are Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals, Gland Pharma, Allergan, Kelun Pharmaceutical, Jiangsu HRS, Qilu Pharmaceutical, Chiatai Tianqing, Hainan Poly Pharm, Yangzijiang Pharmaceutical Industry, Shijiazhuang Pharma Group

What are the Application segmentation covered in the Generic Injection - Market report?

Ans: The Applications covered in the Generic Injection - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Generic Injection - Market report?

Ans: The Types covered in the Generic Injection - Market report are Liquid Injection, Powder for Injection

1 Market Overview
1.1 Generic Injection Product Introduction
1.2 Global Generic Injection Market Size Forecast
1.3 Generic Injection Market Trends & Drivers
1.3.1 Generic Injection Industry Trends
1.3.2 Generic Injection Market Drivers & Opportunity
1.3.3 Generic Injection Market Challenges
1.3.4 Generic Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Generic Injection Players Revenue Ranking (2023)
2.2 Global Generic Injection Revenue by Company (2019-2024)
2.3 Key Companies Generic Injection Manufacturing Base Distribution and Headquarters
2.4 Key Companies Generic Injection Product Offered
2.5 Key Companies Time to Begin Mass Production of Generic Injection
2.6 Generic Injection Market Competitive Analysis
2.6.1 Generic Injection Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Generic Injection Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Liquid Injection
3.1.2 Powder for Injection
3.2 Global Generic Injection Sales Value by Type
3.2.1 Global Generic Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Generic Injection Sales Value, by Type (2019-2030)
3.2.3 Global Generic Injection Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Generic Injection Sales Value by Application
4.2.1 Global Generic Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Generic Injection Sales Value, by Application (2019-2030)
4.2.3 Global Generic Injection Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Generic Injection Sales Value by Region
5.1.1 Global Generic Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Generic Injection Sales Value by Region (2019-2024)
5.1.3 Global Generic Injection Sales Value by Region (2025-2030)
5.1.4 Global Generic Injection Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Generic Injection Sales Value, 2019-2030
5.2.2 North America Generic Injection Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Generic Injection Sales Value, 2019-2030
5.3.2 Europe Generic Injection Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Generic Injection Sales Value, 2019-2030
5.4.2 Asia Pacific Generic Injection Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Generic Injection Sales Value, 2019-2030
5.5.2 South America Generic Injection Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Generic Injection Sales Value, 2019-2030
5.6.2 Middle East & Africa Generic Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Generic Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Generic Injection Sales Value
6.3 United States
6.3.1 United States Generic Injection Sales Value, 2019-2030
6.3.2 United States Generic Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Generic Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Generic Injection Sales Value, 2019-2030
6.4.2 Europe Generic Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Generic Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Generic Injection Sales Value, 2019-2030
6.5.2 China Generic Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Generic Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Generic Injection Sales Value, 2019-2030
6.6.2 Japan Generic Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Generic Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Generic Injection Sales Value, 2019-2030
6.7.2 South Korea Generic Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Generic Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Generic Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Generic Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Generic Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Generic Injection Sales Value, 2019-2030
6.9.2 India Generic Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Generic Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Profile
7.1.2 Sanofi Main Business
7.1.3 Sanofi Generic Injection Products, Services and Solutions
7.1.4 Sanofi Generic Injection Revenue (US$ Million) & (2019-2024)
7.1.5 Sanofi Recent Developments
7.2 Fresenius
7.2.1 Fresenius Profile
7.2.2 Fresenius Main Business
7.2.3 Fresenius Generic Injection Products, Services and Solutions
7.2.4 Fresenius Generic Injection Revenue (US$ Million) & (2019-2024)
7.2.5 Fresenius Recent Developments
7.3 Viatris
7.3.1 Viatris Profile
7.3.2 Viatris Main Business
7.3.3 Viatris Generic Injection Products, Services and Solutions
7.3.4 Viatris Generic Injection Revenue (US$ Million) & (2019-2024)
7.3.5 Pfizer Recent Developments
7.4 Pfizer
7.4.1 Pfizer Profile
7.4.2 Pfizer Main Business
7.4.3 Pfizer Generic Injection Products, Services and Solutions
7.4.4 Pfizer Generic Injection Revenue (US$ Million) & (2019-2024)
7.4.5 Pfizer Recent Developments
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Profile
7.5.2 Teva Pharmaceuticals Main Business
7.5.3 Teva Pharmaceuticals Generic Injection Products, Services and Solutions
7.5.4 Teva Pharmaceuticals Generic Injection Revenue (US$ Million) & (2019-2024)
7.5.5 Teva Pharmaceuticals Recent Developments
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Profile
7.6.2 Hikma Pharmaceuticals Main Business
7.6.3 Hikma Pharmaceuticals Generic Injection Products, Services and Solutions
7.6.4 Hikma Pharmaceuticals Generic Injection Revenue (US$ Million) & (2019-2024)
7.6.5 Hikma Pharmaceuticals Recent Developments
7.7 Novartis
7.7.1 Novartis Profile
7.7.2 Novartis Main Business
7.7.3 Novartis Generic Injection Products, Services and Solutions
7.7.4 Novartis Generic Injection Revenue (US$ Million) & (2019-2024)
7.7.5 Novartis Recent Developments
7.8 Amneal Pharmaceuticals
7.8.1 Amneal Pharmaceuticals Profile
7.8.2 Amneal Pharmaceuticals Main Business
7.8.3 Amneal Pharmaceuticals Generic Injection Products, Services and Solutions
7.8.4 Amneal Pharmaceuticals Generic Injection Revenue (US$ Million) & (2019-2024)
7.8.5 Amneal Pharmaceuticals Recent Developments
7.9 Gland Pharma
7.9.1 Gland Pharma Profile
7.9.2 Gland Pharma Main Business
7.9.3 Gland Pharma Generic Injection Products, Services and Solutions
7.9.4 Gland Pharma Generic Injection Revenue (US$ Million) & (2019-2024)
7.9.5 Gland Pharma Recent Developments
7.10 Allergan
7.10.1 Allergan Profile
7.10.2 Allergan Main Business
7.10.3 Allergan Generic Injection Products, Services and Solutions
7.10.4 Allergan Generic Injection Revenue (US$ Million) & (2019-2024)
7.10.5 Allergan Recent Developments
7.11 Kelun Pharmaceutical
7.11.1 Kelun Pharmaceutical Profile
7.11.2 Kelun Pharmaceutical Main Business
7.11.3 Kelun Pharmaceutical Generic Injection Products, Services and Solutions
7.11.4 Kelun Pharmaceutical Generic Injection Revenue (US$ Million) & (2019-2024)
7.11.5 Kelun Pharmaceutical Recent Developments
7.12 Jiangsu HRS
7.12.1 Jiangsu HRS Profile
7.12.2 Jiangsu HRS Main Business
7.12.3 Jiangsu HRS Generic Injection Products, Services and Solutions
7.12.4 Jiangsu HRS Generic Injection Revenue (US$ Million) & (2019-2024)
7.12.5 Jiangsu HRS Recent Developments
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Profile
7.13.2 Qilu Pharmaceutical Main Business
7.13.3 Qilu Pharmaceutical Generic Injection Products, Services and Solutions
7.13.4 Qilu Pharmaceutical Generic Injection Revenue (US$ Million) & (2019-2024)
7.13.5 Qilu Pharmaceutical Recent Developments
7.14 Chiatai Tianqing
7.14.1 Chiatai Tianqing Profile
7.14.2 Chiatai Tianqing Main Business
7.14.3 Chiatai Tianqing Generic Injection Products, Services and Solutions
7.14.4 Chiatai Tianqing Generic Injection Revenue (US$ Million) & (2019-2024)
7.14.5 Chiatai Tianqing Recent Developments
7.15 Hainan Poly Pharm
7.15.1 Hainan Poly Pharm Profile
7.15.2 Hainan Poly Pharm Main Business
7.15.3 Hainan Poly Pharm Generic Injection Products, Services and Solutions
7.15.4 Hainan Poly Pharm Generic Injection Revenue (US$ Million) & (2019-2024)
7.15.5 Hainan Poly Pharm Recent Developments
7.16 Yangzijiang Pharmaceutical Industry
7.16.1 Yangzijiang Pharmaceutical Industry Profile
7.16.2 Yangzijiang Pharmaceutical Industry Main Business
7.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Products, Services and Solutions
7.16.4 Yangzijiang Pharmaceutical Industry Generic Injection Revenue (US$ Million) & (2019-2024)
7.16.5 Yangzijiang Pharmaceutical Industry Recent Developments
7.17 Shijiazhuang Pharma Group
7.17.1 Shijiazhuang Pharma Group Profile
7.17.2 Shijiazhuang Pharma Group Main Business
7.17.3 Shijiazhuang Pharma Group Generic Injection Products, Services and Solutions
7.17.4 Shijiazhuang Pharma Group Generic Injection Revenue (US$ Million) & (2019-2024)
7.17.5 Shijiazhuang Pharma Group Recent Developments
8 Industry Chain Analysis
8.1 Generic Injection Industrial Chain
8.2 Generic Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Generic Injection Sales Model
8.5.2 Sales Channel
8.5.3 Generic Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Generic Injection Market Trends
    Table 2. Generic Injection Market Drivers & Opportunity
    Table 3. Generic Injection Market Challenges
    Table 4. Generic Injection Market Restraints
    Table 5. Global Generic Injection Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Generic Injection Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Generic Injection Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Generic Injection Product Type
    Table 9. Key Companies Time to Begin Mass Production of Generic Injection
    Table 10. Global Generic Injection Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Generic Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Generic Injection Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Generic Injection Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Generic Injection Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Generic Injection Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Generic Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Generic Injection Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Generic Injection Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Generic Injection Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Generic Injection Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Generic Injection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Generic Injection Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Generic Injection Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Generic Injection Sales Value by Region (2019-2024) & (%)
    Table 27. Global Generic Injection Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Generic Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Generic Injection Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Generic Injection Sales Value, (2025-2030) & (US$ Million)
    Table 31. Sanofi Basic Information List
    Table 32. Sanofi Description and Business Overview
    Table 33. Sanofi Generic Injection Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Generic Injection Business of Sanofi (2019-2024)
    Table 35. Sanofi Recent Developments
    Table 36. Fresenius Basic Information List
    Table 37. Fresenius Description and Business Overview
    Table 38. Fresenius Generic Injection Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Generic Injection Business of Fresenius (2019-2024)
    Table 40. Fresenius Recent Developments
    Table 41. Viatris Basic Information List
    Table 42. Viatris Description and Business Overview
    Table 43. Viatris Generic Injection Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Generic Injection Business of Viatris (2019-2024)
    Table 45. Viatris Recent Developments
    Table 46. Pfizer Basic Information List
    Table 47. Pfizer Description and Business Overview
    Table 48. Pfizer Generic Injection Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Generic Injection Business of Pfizer (2019-2024)
    Table 50. Pfizer Recent Developments
    Table 51. Teva Pharmaceuticals Basic Information List
    Table 52. Teva Pharmaceuticals Description and Business Overview
    Table 53. Teva Pharmaceuticals Generic Injection Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Generic Injection Business of Teva Pharmaceuticals (2019-2024)
    Table 55. Teva Pharmaceuticals Recent Developments
    Table 56. Hikma Pharmaceuticals Basic Information List
    Table 57. Hikma Pharmaceuticals Description and Business Overview
    Table 58. Hikma Pharmaceuticals Generic Injection Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Generic Injection Business of Hikma Pharmaceuticals (2019-2024)
    Table 60. Hikma Pharmaceuticals Recent Developments
    Table 61. Novartis Basic Information List
    Table 62. Novartis Description and Business Overview
    Table 63. Novartis Generic Injection Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Generic Injection Business of Novartis (2019-2024)
    Table 65. Novartis Recent Developments
    Table 66. Amneal Pharmaceuticals Basic Information List
    Table 67. Amneal Pharmaceuticals Description and Business Overview
    Table 68. Amneal Pharmaceuticals Generic Injection Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Generic Injection Business of Amneal Pharmaceuticals (2019-2024)
    Table 70. Amneal Pharmaceuticals Recent Developments
    Table 71. Gland Pharma Basic Information List
    Table 72. Gland Pharma Description and Business Overview
    Table 73. Gland Pharma Generic Injection Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Generic Injection Business of Gland Pharma (2019-2024)
    Table 75. Gland Pharma Recent Developments
    Table 76. Allergan Basic Information List
    Table 77. Allergan Description and Business Overview
    Table 78. Allergan Generic Injection Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Generic Injection Business of Allergan (2019-2024)
    Table 80. Allergan Recent Developments
    Table 81. Kelun Pharmaceutical Basic Information List
    Table 82. Kelun Pharmaceutical Description and Business Overview
    Table 83. Kelun Pharmaceutical Generic Injection Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Generic Injection Business of Kelun Pharmaceutical (2019-2024)
    Table 85. Kelun Pharmaceutical Recent Developments
    Table 86. Jiangsu HRS Basic Information List
    Table 87. Jiangsu HRS Description and Business Overview
    Table 88. Jiangsu HRS Generic Injection Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Generic Injection Business of Jiangsu HRS (2019-2024)
    Table 90. Jiangsu HRS Recent Developments
    Table 91. Qilu Pharmaceutical Basic Information List
    Table 92. Qilu Pharmaceutical Description and Business Overview
    Table 93. Qilu Pharmaceutical Generic Injection Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Generic Injection Business of Qilu Pharmaceutical (2019-2024)
    Table 95. Qilu Pharmaceutical Recent Developments
    Table 96. Chiatai Tianqing Basic Information List
    Table 97. Chiatai Tianqing Description and Business Overview
    Table 98. Chiatai Tianqing Generic Injection Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Generic Injection Business of Chiatai Tianqing (2019-2024)
    Table 100. Chiatai Tianqing Recent Developments
    Table 101. Hainan Poly Pharm Basic Information List
    Table 102. Hainan Poly Pharm Description and Business Overview
    Table 103. Hainan Poly Pharm Generic Injection Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Generic Injection Business of Hainan Poly Pharm (2019-2024)
    Table 105. Hainan Poly Pharm Recent Developments
    Table 106. Yangzijiang Pharmaceutical Industry Basic Information List
    Table 107. Yangzijiang Pharmaceutical Industry Description and Business Overview
    Table 108. Yangzijiang Pharmaceutical Industry Generic Injection Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Generic Injection Business of Yangzijiang Pharmaceutical Industry (2019-2024)
    Table 110. Yangzijiang Pharmaceutical Industry Recent Developments
    Table 111. Shijiazhuang Pharma Group Basic Information List
    Table 112. Shijiazhuang Pharma Group Description and Business Overview
    Table 113. Shijiazhuang Pharma Group Generic Injection Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Generic Injection Business of Shijiazhuang Pharma Group (2019-2024)
    Table 115. Shijiazhuang Pharma Group Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. Generic Injection Downstream Customers
    Table 119. Generic Injection Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Generic Injection Product Picture
    Figure 2. Global Generic Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Generic Injection Sales Value (2019-2030) & (US$ Million)
    Figure 4. Generic Injection Report Years Considered
    Figure 5. Global Generic Injection Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Generic Injection Revenue in 2023
    Figure 7. Generic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Liquid Injection Picture
    Figure 9. Powder for Injection Picture
    Figure 10. Global Generic Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Generic Injection Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Others
    Figure 15. Global Generic Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Generic Injection Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Generic Injection Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Generic Injection Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Generic Injection Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Generic Injection Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Generic Injection Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Generic Injection Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Generic Injection Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Generic Injection Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Generic Injection Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Generic Injection Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Generic Injection Sales Value (%), (2019-2030)
    Figure 28. United States Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Generic Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Generic Injection Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Generic Injection Sales Value by Application (%), 2023 VS 2030
    Figure 49. Generic Injection Industrial Chain
    Figure 50. Generic Injection Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Platinum-based Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-6P8206
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Ether Solvent for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-22W13490
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Clinical Trial Imaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0Z6112
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Smart Pills and Drugs Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5Q14261
Fri Nov 22 00:00:00 UTC 2024

Add to Cart